Biosyent Inc (BIOYF)
7.49
-0.13
(-1.71%)
USD |
OTCM |
Jun 28, 16:00
Biosyent 1 Year Total Returns (Daily): 38.68% for June 28, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 28, 2024 | 38.68% |
| June 27, 2024 | 39.07% |
| June 26, 2024 | 38.82% |
| June 25, 2024 | 42.52% |
| June 24, 2024 | 44.77% |
| June 21, 2024 | 39.64% |
| June 20, 2024 | 36.60% |
| June 18, 2024 | 33.44% |
| June 17, 2024 | 31.17% |
| June 14, 2024 | 32.49% |
| June 13, 2024 | 28.00% |
| June 12, 2024 | 27.36% |
| June 11, 2024 | 21.88% |
| June 10, 2024 | 21.88% |
| June 07, 2024 | 25.46% |
| June 06, 2024 | 22.79% |
| June 05, 2024 | 22.52% |
| June 04, 2024 | 22.52% |
| June 03, 2024 | 22.52% |
| May 31, 2024 | 27.18% |
| May 30, 2024 | 26.11% |
| May 29, 2024 | 22.85% |
| May 28, 2024 | 29.16% |
| May 24, 2024 | 18.01% |
| May 23, 2024 | 17.91% |
| Date | Value |
|---|---|
| May 22, 2024 | 24.50% |
| May 21, 2024 | 22.85% |
| May 20, 2024 | 29.91% |
| May 17, 2024 | 20.68% |
| May 16, 2024 | 12.69% |
| May 15, 2024 | 12.51% |
| May 14, 2024 | 11.50% |
| May 13, 2024 | 14.76% |
| May 10, 2024 | 12.76% |
| May 09, 2024 | 12.76% |
| May 08, 2024 | 12.76% |
| May 07, 2024 | 12.76% |
| May 06, 2024 | 12.76% |
| May 03, 2024 | 18.00% |
| May 02, 2024 | 15.07% |
| May 01, 2024 | 15.07% |
| April 30, 2024 | 14.91% |
| April 29, 2024 | 15.09% |
| April 26, 2024 | 8.64% |
| April 25, 2024 | 8.64% |
| April 24, 2024 | 8.64% |
| April 23, 2024 | 10.90% |
| April 22, 2024 | 10.90% |
| April 19, 2024 | 10.48% |
| April 18, 2024 | 10.48% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-64.88%
Minimum
Mar 18 2020
171.6%
Maximum
Mar 18 2021
5.36%
Average
3.85%
Median
1 Year Total Returns (Daily) Benchmarks
| Acasti Pharma Inc | -7.30% |
| Aurinia Pharmaceuticals Inc | -38.02% |
| Edesa Biotech Inc | -26.60% |
| Lexaria Bioscience Corp | 273.1% |
| Xenon Pharmaceuticals Inc | -3.46% |